Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution

Pediatrics

Volumn 116, Issue 1, 2005, Pages 61-67

  Abelson, Jonathan A ^a   Moore, Theodore ^b   Bruckner, David ^c   Deville, Jaime ^b   Nielsen, Karin ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MATTEL CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fungal infections children; Fungemia pediatrics; Immunocompromised patients; Nosocomial infections

Indexed keywords

BACTERIUM CULTURE; BLOOD FLOW; CANDIDA; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; FUNGAL COLONIZATION; FUNGEMIA; FUNGUS CULTURE; FUNGUS ISOLATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LABORATORY TEST; MICROBIOLOGY; MORBIDITY; MORTALITY; PEDIATRICS; PRIORITY JOURNAL; REVIEW; TERTIARY HEALTH CARE; UNITED STATES; ADOLESCENT; ADULT; ARTICLE; CANDIDIASIS; CHILD; CROSS INFECTION; IMMUNE DEFICIENCY; INFANT; ISOLATION AND PURIFICATION; PRESCHOOL CHILD; RISK FACTOR; SURVIVAL RATE;

ADOLESCENT; ADULT; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FUNGEMIA; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; RISK FACTORS; SURVIVAL RATE;

EID: 33644625022     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-1605     Document Type: Review

References (23)

1. McNeil MM, Nash SL, Hajjeh RA, et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis. 2001;33:641-647
2. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States. Pediatrics. 1999;103(4). Available at: www.pediatrics.org/cgi/content/full/103/4/e39
3. Jarvis WR, Edwards JR, Culver DH, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med. 1991;91:185S-191S
4. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 1989;149:2349-2353
5. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev. 1996;9:499-511
6. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis. 2002;627-630
7. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med. 1991;91:86S-89S
8. Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis. 1993;167:1247-1251
9. Debusk CH, Daoud R, Thirumoorthi MC, Wilson FM, Khatib R. Candidemia: current epidemiologic characteristics and a long-term follow-up of the survivors. Scand J Infect Dis. 1994;26:697-703
10. Pittet D, Wenzel RP. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med. 1995;155:1177-1184
11. Macphail GL, Taylor GD, Buchanan-Chell M, Ross C, Wilson S, Kureishi A. Epidemiology, treatment and outcome of candidemia: a five-year review at three Canadian hospitals. Mycoses. 2002;45:141-145
12. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis. 1995;20:1526-1530
13. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis. 1999;29:239-244
14. Kao AS, Brandt ME, Pruitt WR, et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis. 1999;29:1164-1170
15. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med. 1988;148:2642-2645
16. Meunier F, Aoun M, Bitar N. Candidemia in immunocompromised patients. Clin Infect Dis. 1992;14(suppl 1):S120-S125
17. Bross J, Talbot GH, Maislin G, Hurwitz S, Strom BL. Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. Am J Med. 1989;87:614-620
18. Gladdy RA, Richardson SE, Davies HD, Superina RA. Candida infection in pediatric liver transplant patients. Liver Transpl Surg. 1999;5:e16-e24
19. Rosen GP, Nielsen K, Bowles L, Moore TB. Patterns of fungal infections in pediatric hematology and oncology patients at UCLA from 1991-2001 [abstract 1658]. Pediatr Res. 2003;53:291A
20. Levy I, Rubin LG, Vasishtha S, Tucci V, Sood SK. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis. 1998;26:1086-1088
21. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J. 1998;17:504-508
22. Cahan H, Deville JG. Invasive fungal infections in a neonatal intensive care unit: a five year retrospective review [abstract 355]. Presented at the 41st Annual Meeting of the Infectious Diseases Society of America; October 9-12, 2003; San Diego, CA
23. Pfaller MA, Messer SA, Houston A, et al. National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis. 1998;31:289-296